Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards Perimount pericardial bioprosthesis

Journal of Thoracic and Cardiovascular Surgery

Volumn 127, Issue 4, 2004, Pages 1166-1170

  Mistiaen, Wilhelm ^a   Van Cauwelaert, Ph ^b   Muylaert, Ph ^b   Sys, S U ^c   Harrisson, F ^a   Bortier, H ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b MIDDELHEIM HOSPITAL   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; WARFARIN;

AGE; AGED; AORTA VALVE REPLACEMENT; ARTICLE; BIOPROSTHESIS; CAROTID ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY; DIABETES MELLITUS; ENDOCARDITIS; FEMALE; HEART ATRIUM FIBRILLATION; HEART VALVE PROSTHESIS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERICARDIUM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SEX; SURGICAL RISK; THROMBOEMBOLISM;

EID: 1842506203     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2003.11.010     Document Type: Article

References (25)

1. Edmunds LH Jr, Clark RE, Cohn LH, et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. J Thorac Cardiovasc Surg. 1996;112:708-11.
2. Butchart EG, Moreno de la Santa P, Rooney SJ, et al. Arterial risk factors and ischaemic cerebrovascular events after aortic valve replacement. J Heart Valve Dis. 1995;4:1-8.
3. Aupart MR, Sirinelli AL, Diemont FF, et al. The last generation of pericardial valves in the aortic position: ten-year follow-up in 589 patients. Ann Thorac Surg. 1996;61:615-20.
4. Torka MC, Salefsky BE, Hacker RW. Intermediate clinical results after aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis. Ann Thorac Surg. 1995;60(suppl):S311-5.
5. Edwards TI, Livesey SA, Simpson IA, et al. Biological valves beyond fifteen years: the Wessex experience. Ann Thorac Surg. 1995: 60(suppl):S211-5.
6. Jamieson WRE, Munro AI, Miyagishima RT. Carpentier-Edwards standard porcine bioprosthesis: clinical performance to seventeen years. Ann Thorac Surg. 1995;60:999-1007.
7. Dodge A, Hurni M, Ruchat P, et al. Surgery in native valve endocarditis: indications, results and risk factors. Eur J Cardiothorac Surg. 1995;9:330-4.
8. Grunenfelder I, Akins CW, Hilgenberg AD, et al. Long-term results and determinants of mortality after surgery for native and prosthetic valve endocarditis. J Heart Valve Dis. 2001;10:694-702.
9. Medalion B, Lytle BW, McCarthy PM, et al. Aortic valve replacement for octogenarians: are small valves bad? Ann Thorac Surg. 1999;67:1543-4.
10. Adams DH, Chen RH, Kadner A, et al. Impact of small prosthetic valve size on operative mortality in elderly patients after aortic valve replacement for aortic stenosis: does gender matter? J Thorac Cardiovasc Surg. 1999;118:815-22.
11. Cernaianu AC, Vassilidze TV, Flum DR, et al. Predictors of stroke after cardiac surgery. J Card Surg. 1995;10:334-9.
12. Attum AA, Girardet R, Barbie R, et al. Risks of cerebrovascular events related to open heart surgery. J Ky Med Assoc. 1998;96(8):290-5.
13. Stamou SC, Hill PC, Dangas G, et al. Stroke after coronary artery bypass: incidence, predictors and clinical outcome. Stroke. 2001;32:1508-13.
14. Cohn LH, Collins JJ Jr, Rizzo RJ, et al. Twenty-year follow-up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg. 1998;66(suppl 6):S30-4.
15. Helft G, Tabone X, Georges JL, et al. Bioprosthetic valve replacement in elderly. Eur Heart J. 1995;16:529-33.
16. Blair KL, Hatton AC, White D, et al. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve. Circulation. 1994;90(suppl II):II214-9.
17. Pellerin M, Mihaileanu S, Couëtil JP, et al. Carpentier-Edwards bioprosthesis in aortic position: long-term follow-up: 1980 to 1994. Ann Thorac Surg. 1995;60(suppl):S292-6.
18. Debetaz LF, Ruchat P, Hurni M, et al. St Jude Medical valve prosthesis: an analysis of long-term outcome and prognostic factors. J Thorac Cardiovasc Surg. 1997;113:134-48.
19. Kvidal P, Bergstrom R, Malm T, et al. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J. 2000;21:1099-111.
20. Orgles CS, Chakraverty S, Gopichandran TD. Carotid stenosis in the real world: can Doppler ultrasound replace angiography in a district hospital setting? Clin Radiol. 1999;54:655-8.
21. Shanik GD, Moore JD, Leahy A, et al. Asymptomatic carotid lesion, a benign lesion? Eur J Vasc Surg. 1992;6:10-5.
22. Lund O, Magnussen K, Knudsen M, et al. The potential for normal long term survival and morbidity rates after aortic valve replacement for aortic stenosis. J Heart Valve Dis. 1996;5:258-67.
23. Elayda MA, Hall RJ, Reul RM, et al. Aortic valve replacement in patients of 80 years and older. Operative risks and long-term results. Circulation. 1993;88(suppl II):II11-6.
24. Glower DD, Landolfo KP, Cheruvu S, et al. Determinants of 15 year outcome with 1,119 standard Carpentier-Edwards porcine valves. Ann Thorac Surg. 1998;66(suppl 6):S44-8.
25. Ruggeri ZM. Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost. 1993;70:119-23.